AIRLINK 197.00 Decreased By ▼ -4.24 (-2.11%)
BOP 10.02 Increased By ▲ 0.05 (0.5%)
CNERGY 7.33 Increased By ▲ 0.44 (6.39%)
FCCL 35.70 Increased By ▲ 0.34 (0.96%)
FFL 16.94 Decreased By ▼ -0.21 (-1.22%)
FLYNG 25.20 Increased By ▲ 0.99 (4.09%)
HUBC 134.00 Decreased By ▼ -4.19 (-3.03%)
HUMNL 14.03 Decreased By ▼ -0.04 (-0.28%)
KEL 4.80 Decreased By ▼ -0.06 (-1.23%)
KOSM 6.88 Increased By ▲ 0.22 (3.3%)
MLCF 44.50 Decreased By ▼ -1.81 (-3.91%)
OGDC 217.99 Decreased By ▼ -4.55 (-2.04%)
PACE 6.95 Decreased By ▼ -0.11 (-1.56%)
PAEL 41.00 Decreased By ▼ -2.14 (-4.96%)
PIAHCLA 16.85 Decreased By ▼ -0.18 (-1.06%)
PIBTL 8.45 Decreased By ▼ -0.09 (-1.05%)
POWER 9.35 Increased By ▲ 0.25 (2.75%)
PPL 184.03 Decreased By ▼ -4.73 (-2.51%)
PRL 40.75 Decreased By ▼ -2.52 (-5.82%)
PTC 24.75 Decreased By ▼ -0.60 (-2.37%)
SEARL 103.40 Decreased By ▼ -7.02 (-6.36%)
SILK 1.01 Decreased By ▼ -0.02 (-1.94%)
SSGC 40.48 Decreased By ▼ -2.16 (-5.07%)
SYM 18.00 Decreased By ▼ -0.57 (-3.07%)
TELE 8.80 Decreased By ▼ -0.32 (-3.51%)
TPLP 12.75 Decreased By ▼ -0.93 (-6.8%)
TRG 66.80 Decreased By ▼ -1.36 (-2%)
WAVESAPP 11.30 Increased By ▲ 1.03 (10.03%)
WTL 1.78 Decreased By ▼ -0.09 (-4.81%)
YOUW 4.03 Increased By ▲ 0.02 (0.5%)
BR100 12,077 Decreased By -142.4 (-1.17%)
BR30 36,524 Decreased By -793.3 (-2.13%)
KSE100 115,042 Decreased By -802.6 (-0.69%)
KSE30 36,200 Decreased By -276.6 (-0.76%)

WASHINGTON: US doctors announced Thursday they had successfully performed a double lung transplant on a patient with terminal lung cancer, giving new hope to others who also have advanced stages of the deadly disease.

Albert Khoury, a 54-year-old non-smoker, underwent a seven-hour surgery to receive his new lungs at Northwestern Medicine in Chicago on September 25, 2021.

Six months on, the lungs are working well and he has no signs of cancer in his body.

“Lung transplantation for lung cancer is extremely uncommon with few cases reported,” Ankit Bharat, chief of thoracic surgery at Northwestern Medicine, said in a statement.

“For patients with stage 4 cancer, lung transplantation is considered a complete ‘no-no,’ but because Albert’s cancer was confined only to his chest, we were confident we could clear all the cancer during surgery and save his life.” Surgeons are generally reluctant to proceed with such transplants because if there are even a few cancerous cells remaining, there is a strong chance they will regrow in a patient taking immune-suppressing medications to prevent organ rejection.

The few such procedures in the past have not been successful, but since then, advances have allowed doctors to better understand cancer’s spread.

Comments

Comments are closed.